Infectious Disease

  • Paxlovid, effective in preventing severe COVID-19, didn’t appear to help long-COVID patients in this single-center study. But further research may show benefits with different doses or for people with specific symptoms.

  • A.C. Matin dies at 83

    The microbiologist, on the faculty for nearly half a century, studied a wide range of topics, including antibiotic resistance, cancer, and bacteria as an agent for cleaning up toxic chemicals.

  • Wes Brown dies at 63

    Brown developed stem-cell therapies for patients who suffered infections after receiving blood or bone marrow transplants.

  • Unexpected cells may spread COVID-19

    A previously overlooked type of immune cell allows SARS-CoV-2 to proliferate, Stanford Medicine scientists have found. The discovery has important implications for preventing severe COVID-19.

  • Who needs regular COVID-19 boosters?

    A study led by researchers at Stanford Medicine finds the benefit of frequent booster vaccination for COVID-19 is highest for those over 65 years and the immunocompromised.

  • Why young kids don’t get severe COVID

    Children’s noses pack a punch that could help explain COVID-19’s typically mild course in young kids. Researchers hope to parlay that ‘nasal magic’ into increased protections for adults.

  • William Robinson, pioneering virologist

    Hard-driving molecular virologist who used ‘advanced chemistry to unlock the tightly held secrets of viruses’ was also a hearty mountain man, scaling peaks in Alaska and Nepal.

  • New COVID-19 vaccine

    In a study led by Stanford Medicine researchers, a low-cost COVID-19 vaccine that does not require refrigeration provided immunity in rhesus monkeys for one year.

  • mRNA vaccine beats infection

    Stanford Medicine researchers have shown that prior SARS-CoV-2 infection reduces killer T cells’ response to vaccination. These cells are crucial for eliminating the virus from the body.

  • Long-COVID clinical trials underway

    Developing the right treatment for long COVID depends on figuring out what’s causing it. Stanford Medicine researchers are bent on learning more about the people who have it to find out.

  • New app detects mpox

    Researchers were able to devise an app that can determine which skin lesions are caused by mpox with an accuracy of 90%.

  • One-and-done COVID-19 drug successful

    A single dose of lambda-interferon reduced hospitalization among COVID-19 outpatients in a late-stage study spearheaded by a Stanford Medicine virologist.